Email: cspc@cspc.cn
News
News Center
Jan. 11
2024
Multiple Research Results of CSPC Unveiled at ASH Annual Meeting
CSPC Subsidiary Awarded Provincial Engineering Research Center
CSPC Listed in Global Top 500 Enterprises in R&D Investment
Dec. 27
2023
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NEW DRUG APPLICATION FOR IRINOTECAN LIPOSOME INJECTION TO U.S. FDA
Dec. 14
VOLUNTARY ANNOUNCEMENT - DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULPHATE ORALLY DISINTEGRATING TABLETS OBTAINS CLINICAL TRIAL APPROVAL
Dec. 08
VOLUNTARY ANNOUNCEMENT - BIVALENT COVID-19 mRNA VACCINE (SYS6006.32) INCLUDED FOR EMERGENCY USE IN CHINA
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
